Finance
Markets
No recent trading data. The last price we hold for HUM is from Jun 3 (48 days ago). This symbol may be delisted, renamed, or halted — the figures below reflect its last active session, not the current market.

HUM

stock Healthcare Healthcare Plans
Humana
$327.75 +6.87 (+2.14%) Delayed · quoted 47d ago
Mixed 48% Climbing

What the indicators say

Mixed 4 of 5 trend signals bullish
Momentum · RSI 14 Overbought
75
0oversold 30overbought 70100

RSI 75 — overbought: momentum is stretched and may be due for a pullback.

EMA 21 $294.17
Above
Near-term trend is up
SMA 50 $241.02
Above
Medium-term trend is up
SMA 200 $245.24
Above
Long-term trend is up
50 / 200-day
Death cross
50-day below the 200-day — bearish
Supertrend $293.89
Uptrend
Price is holding above the Supertrend band — bullish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jun 3

The day open and close within the day's range
Low $324.14 High $332.26
Open
$327.75
+2.14%
Close
$327.75
+2.14%
52-week range where the price sits across its year
52w low $163.11 52w high $333.31
Current
$327.75
Prev close
$320.88
Volume 0.56× the 3-month average
0 avg 2× avg
Today
958.38K
3-mo avg
1.72M

Earningscalendar synced from Yahoo 57d ago

Most recent
Apr 2983 days ago
Next expected
Jul 29in 8 days

Recent earnings dates

  • Apr 29 83 days ago
  • Feb 11 160 days ago
  • Nov 5, 2025 258 days ago
  • Jul 30, 2025 356 days ago

Past earnings dates come from HUM’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 51d ago

Fair

Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), HUM’s fundamentals read as fair overall.

P/E ratio Fair
35.0x

At 35.0x, investors are paying up; a fair amount of future growth is already in the price.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Fair
1.08%

A 1.1% yield is modest: a small income on top of whatever the share price does.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Weak
0.9%

A 0.9% margin is thin; little of each revenue dollar survives as profit.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Fair
6.7%

A 6.7% return on equity is respectable, in the normal range.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Fair
2.4%

A 2.4% return on assets is reasonable for a company of this kind.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity Fair
1.77

At 1.77, the company carries a moderate, manageable amount of debt.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Strong
2.00

At 2.00, short-term assets comfortably cover short-term bills.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Strong
+10.1%

Revenue grew 10.1% from the prior year: strong top-line expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Weak
-1.6%

Net income fell 1.6% from the prior year; profit is shrinking.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 51d ago

FY2021FY2022FY2023FY2024FY2025
Revenue $83.1B$92.9B$106.4B$117.8B$129.7B
Net income $2.9B$2.8B$2.5B$1.2B$1.2B
Diluted EPS $22.67$22.08$20.00$9.98$9.84
Dividend / share $2.73$3.06$3.44$3.54$3.54
Total assets $44.4B$43.1B$47.1B$46.5B$48.9B
Total liabilities $28.3B$27.7B$30.7B$30.0B$31.2B
Shareholder equity $16.1B$15.4B$16.3B$16.4B$17.7B

Leadershipsynced from SEC 56d ago

  • Rechtin James A. President & CEO
  • Mellet Celeste Chief Financial Officer
  • Dintenfass David President, Enterprise Growth
  • Martin Aaron President, Medicare Advantage
  • Mehta Japan Chief Information Officer
  • O'Hara Michelle A. Chief Human Resources Officer
  • Shetty Sanjay K President, CenterWell
  • Ventura Joseph C Chief Legal Officer
  • Field Robert Stuart Director

Officers and board are drawn from HUM’s recent SEC ownership filings (Forms 3, 4 and 5).

Recent leadership changes

Notable recent eventspast year

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Dividendssynced from Yahoo 52d ago

Pays quarterly Fair
2025 total
$3.54
2026 so far
$0.891 payment
2026 projected
$3.54+0.0% vs 2025

Projection scales HUM’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.

Payment history

  • Mar 27 $0.89
  • Dec 26, 2025 $0.89
  • Sep 26, 2025 $0.89
  • Jun 27, 2025 $0.89
  • Mar 28, 2025 $0.89
  • Dec 31, 2024 $0.89
  • Sep 30, 2024 $0.89
  • Jun 28, 2024 $0.89
  • Mar 27, 2024 $0.89
  • Dec 28, 2023 $0.89
  • Sep 28, 2023 $0.89
  • Jun 29, 2023 $0.89
  • Mar 30, 2023 $0.89
  • Dec 29, 2022 $0.79
  • Sep 29, 2022 $0.79
  • Jun 29, 2022 $0.79
  • Mar 30, 2022 $0.79
  • Dec 30, 2021 $0.70
  • Sep 29, 2021 $0.70
  • Jun 29, 2021 $0.70

Recent SEC filingssynced from SEC 51d ago

© 2026 Isaac Bythewood · Some rights reserved